Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. (November 2017)

• Record Type: Journal Article
• Authors: Horikoshi, Yuho; Suwa, Junichi; Higuchi, Hiroshi; Kaneko, Tetsuji; Furuichi, Mihoko; Aizawa, Yuta; Fukuoka, Kahoru; Okazaki, Kaoru; Ito, Kenta; Shoji, Takayo
• Is Part Of: International journal of infectious diseases. Volume 64(2017:Nov.)
• Page Start: 69
• Page End: 73
• Publication Date: 2017-11
• Subjects: Antimicrobial stewardship program -- Antimicrobial resistance -- Children -- Pseudomonas aeruginosa -- Carbapenem -- Day of therapy; Communicable diseases -- Periodicals; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; Electronic journals; 616.9
• DOI: 10.1016/j.ijid.2017.09.012
• Languages: English
• ISSNs: 1201-9712

Abstract

Highlights: An antimicrobial stewardship program in consultation with the infectious disease service reduced resistance in Pseudomonas aeruginosa . Carbapenem use was correlated with carbapenem resistance in P. aeruginosa . This pediatric antimicrobial stewardship program reduced the length of hospitalization and infection-related mortality. Abstract: Objective: The impact of pediatric antimicrobial stewardship programs (ASP) on antimicrobial resistance (AMR) remains largely unknown. This study aimed to evaluate the AMR for carbapenem of Gram-negative bacilli (GNB) and carbapenem use with infectious diseases consultation after the implementation of an ASP. Methods: This quasi-experimental study was conducted at Tokyo Metropolitan Children's Medical Center in Japan. The pre- and post-intervention periods were April 2010 to September 2011 and October 2011 to March 2017, respectively. The pre-intervention phase consisted of consultations with the infectious diseases service alone. The ASP was implemented during the post-intervention phase. The carbapenem resistance rates of GNB were calculated. The correlation between carbapenem resistance rates and carbapenem day of therapy (DOT) was examined. The outcome metrics were compared by average length of hospitalization, all-cause mortality, and infection-related mortality. Results: A positive correlation was observed between the carbapenem resistance rate in Pseudomonas aeruginosa and DOT (0.76, p = 0.04). The carbapenem resistance rate in P. aeruginosa ( p < 0.01) and DOT ( p < 0.01) decreased significantly in the post-intervention period. The length of hospitalization ( p < 0.01) and infection-related mortality ( p = 0.05) decreased in the post-intervention period. Conclusions: A sustained ASP with additional consultation with the infectious disease service reduced carbapenem use and resistance in P. aeruginosa, leading to favorable outcomes in terms of length of hospitalization and infection-related mortality.